Saldova R - Search Results

1

Automated, high-throughput serum glycoprofiling platform.

Stöckmann H, O'Flaherty R, Adamczyk B, Saldova R, Rudd PM. Stöckmann H, et al. Among authors: saldova r. Integr Biol (Camb). 2015 Sep;7(9):1026-32. doi: 10.1039/c5ib00130g. Epub 2015 Jul 20. Integr Biol (Camb). 2015. PMID: 26189827

2

Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG.

Saldova R, Royle L, Radcliffe CM, Abd Hamid UM, Evans R, Arnold JN, Banks RE, Hutson R, Harvey DJ, Antrobus R, Petrescu SM, Dwek RA, Rudd PM. Saldova R, et al. Glycobiology. 2007 Dec;17(12):1344-56. doi: 10.1093/glycob/cwm100. Epub 2007 Sep 20. Glycobiology. 2007. PMID: 17884841

3

Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation.

Arnold JN, Saldova R, Hamid UM, Rudd PM. Arnold JN, et al. Among authors: saldova r. Proteomics. 2008 Aug;8(16):3284-93. doi: 10.1002/pmic.200800163. Proteomics. 2008. PMID: 18646009 Review.

4

A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression.

Abd Hamid UM, Royle L, Saldova R, Radcliffe CM, Harvey DJ, Storr SJ, Pardo M, Antrobus R, Chapman CJ, Zitzmann N, Robertson JF, Dwek RA, Rudd PM. Abd Hamid UM, et al. Among authors: saldova r. Glycobiology. 2008 Dec;18(12):1105-18. doi: 10.1093/glycob/cwn095. Epub 2008 Sep 25. Glycobiology. 2008. PMID: 18818422

5

Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis.

Saldova R, Wormald MR, Dwek RA, Rudd PM. Saldova R, et al. Dis Markers. 2008;25(4-5):219-32. doi: 10.1155/2008/601583. Dis Markers. 2008. PMID: 19126966 Free PMC article. Review.

6

Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia.

Stanta JL, Saldova R, Struwe WB, Byrne JC, Leweke FM, Rothermund M, Rahmoune H, Levin Y, Guest PC, Bahn S, Rudd PM. Stanta JL, et al. Among authors: saldova r. J Proteome Res. 2010 Sep 3;9(9):4476-89. doi: 10.1021/pr1002356. J Proteome Res. 2010. PMID: 20578731

7

Levels of specific glycans significantly distinguish lymph node-positive from lymph node-negative breast cancer patients.

Pierce A, Saldova R, Abd Hamid UM, Abrahams JL, McDermott EW, Evoy D, Duffy MJ, Rudd PM. Pierce A, et al. Among authors: saldova r. Glycobiology. 2010 Oct;20(10):1283-8. doi: 10.1093/glycob/cwq090. Epub 2010 Jun 24. Glycobiology. 2010. PMID: 20581008

8

Glycan characterization of PSA 2-DE subforms from serum and seminal plasma.

Sarrats A, Saldova R, Comet J, O'Donoghue N, de Llorens R, Rudd PM, Peracaula R. Sarrats A, et al. Among authors: saldova r. OMICS. 2010 Aug;14(4):465-74. doi: 10.1089/omi.2010.0050. OMICS. 2010. PMID: 20726802 Free article.

9

Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia.

Saldova R, Fan Y, Fitzpatrick JM, Watson RW, Rudd PM. Saldova R, et al. Glycobiology. 2011 Feb;21(2):195-205. doi: 10.1093/glycob/cwq147. Epub 2010 Sep 22. Glycobiology. 2011. PMID: 20861084

10

Levels of specific serum N-glycans identify breast cancer patients with higher circulating tumor cell counts.

Saldova R, Reuben JM, Abd Hamid UM, Rudd PM, Cristofanilli M. Saldova R, et al. Ann Oncol. 2011 May;22(5):1113-1119. doi: 10.1093/annonc/mdq570. Epub 2010 Dec 1. Ann Oncol. 2011. PMID: 21127012 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters